Proteogenomic Features of the Highly Polymorphic Histidine-rich Glycoprotein Arose Late in Evolution

被引:2
|
作者
Zou, Yang [1 ,2 ,3 ]
van Breukelen, Bas [1 ,2 ,3 ]
Pronker, Matti [1 ,2 ,3 ]
Reiding, Karli [1 ,2 ,3 ]
Heck, Albert J. R. [1 ,2 ,3 ]
机构
[1] Univ Utrecht, Bijvoet Ctr Biomol Res, Biomol Mass Spectrometry & Prote, Utrecht, Netherlands
[2] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands
[3] Netherlands Prote Ctr, Utrecht, Netherlands
关键词
HUMAN-PLASMA-PROTEIN; HIGH-AFFINITY; SWISS-MODEL; SERUM; IDENTIFICATION; BINDING; FIBRINOLYSIS; COAGULATION; FIBRINOGEN; FRAGMENT;
D O I
10.1016/j.mcpro.2023.100585
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Histidine-rich glycoprotein (HRG) is a liver-produced protein circulating in human serum at high concentrations of around 125 mu g/ml. HRG belongs to the family of type-3 cystatins and has been implicated in a plethora of biological processes, albeit that its precise function is still not well understood. Human HRG is a highly polymorphic protein, with at least five variants with minor allele frequencies of more than 10%, variable in populations from different parts of the world. Considering these five mutations we can theoretically expect 3(5) = 243 possible genetic HRG variants in the population. Here, we purified HRG from serum of 44 individual donors and investigated by proteomics the occurrence of different allotypes, each being either homozygote or heterozygote for each of the five mutation sites. We observed that some mutational combinations in HRG were highly favored, while others were apparently missing, although they ought to be present based on the independent assembly of these five mutation sites. To further explore this behavior, we extracted data from the 1000 genome project (n similar to 2500 genomes) and assessed the frequency of different HRG mutants in this larger dataset, observing a prevailing agreement with our proteomics data. From all the proteogenomic data we conclude that the five different mutation sites in HRG are not occurring independently, but several mutations at different sites are fully mutually exclusive, whereas others are highly intwined. Specific mutations do also affect HRG glycosylation. As the levels of HRG have been suggested as a protein biomarker in a variety of biological processes (e.g., aging, COVID-19 severity, severity of bacterial infections), we here conclude that the highly polymorphic nature of the protein needs to be considered in such proteomics evaluations, as these mutations may affect HRG's abundance, structure, posttranslational modifications, and function.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] HISTIDINE-RICH GLYCOPROTEIN LEVELS IN CHILDREN - THE EFFECT OF AGE
    CORRIGAN, JJ
    JETER, MA
    BRUCK, D
    FEINBERG, WM
    THROMBOSIS RESEARCH, 1990, 59 (03) : 681 - 686
  • [42] Histidine-rich glycoprotein plus zinc to neutralize heparin
    Fu, CL
    Horne, MK
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2002, 139 (04): : 211 - 217
  • [43] CONGENITAL HISTIDINE-RICH GLYCOPROTEIN DEFICIENCY ASSOCIATED WITH THROMBOSIS
    SHIGEKIYO, T
    OHSHIMA, T
    OKA, H
    TOMONARI, A
    AZUMA, H
    SAITO, S
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1256 - 1256
  • [44] Messenger RNA of the Histidine-Rich Glycoprotein in Breast Tumors
    A. I. Autenshlyus
    I. I. Brusentsov
    I. O. Marinkin
    S. A. Smirnova
    M. Yu. Rukavishnikov
    V. V. Lyakhovich
    Doklady Biochemistry and Biophysics, 2018, 478 : 37 - 40
  • [45] IDENTIFICATION OF HISTIDINE-RICH GLYCOPROTEIN IN HUMAN COLOSTRUM AND MILK
    HUTCHENS, TW
    YIP, TT
    MORGAN, WT
    PEDIATRIC RESEARCH, 1992, 31 (03) : 239 - 246
  • [46] Messenger RNA of the Histidine-Rich Glycoprotein in Breast Tumors
    Autenshlyus, A. I.
    Brusentsov, I. I.
    Marinkin, I. O.
    Smirnova, S. A.
    Rukavishnikov, M. Yu.
    Lyakhovich, V. V.
    DOKLADY BIOCHEMISTRY AND BIOPHYSICS, 2018, 478 (01) : 37 - 40
  • [47] Histidine-rich glycoprotein as an excellent biomarker for sepsis and beyond
    Nishibori, Masahiro
    Wake, Hidenori
    Morimatsu, Hiroshi
    CRITICAL CARE, 2018, 22
  • [48] TURNOVER OF HISTIDINE-RICH GLYCOPROTEIN DURING HEPARIN ADMINISTRATION IN MAN
    LIJNEN, HR
    COLLEN, D
    THROMBOSIS RESEARCH, 1983, 30 (06) : 671 - 676
  • [49] Arterial thrombosis is accelerated in mice deficient in histidine-rich glycoprotein
    Vu, Trang T.
    Zhou, Ji
    Leslie, Beverly A.
    Stafford, Alan R.
    Fredenburgh, James C.
    Ni, Ran
    Qiao, Shengjun
    Vaezzadeh, Nima
    Jahnen-Dechent, Willi
    Monia, Brett P.
    Gross, Peter L.
    Weitz, Jeffrey I.
    BLOOD, 2015, 125 (17) : 2712 - 2719
  • [50] Interactions of histidine-rich glycoprotein with immunoglobulins and proteins of the complement system
    Manderson, G. A.
    Martin, M.
    Onnerfjord, P.
    Saxne, T.
    Schmidtchen, A.
    Mollnes, T. E.
    Heinegard, D.
    Blom, A. M.
    MOLECULAR IMMUNOLOGY, 2009, 46 (16) : 3388 - 3398